SPDSYN1 Antibody

Shipped with Ice Packs
In Stock

Description

Synapsin I (SYN1) Antibodies: Key Features and Applications

Synapsin I (SYN1) is a neuronal phosphoprotein encoded by the SYN1 gene, essential for synaptic vesicle trafficking and neurotransmitter release . Antibodies targeting SYN1 are widely used to study synaptic plasticity and neurodevelopmental disorders.

Key Findings:

  • SYN1 antibodies detect isoforms and post-translational modifications critical for synaptic function .

  • Cross-reactivity with non-target proteins (e.g., neurofilaments) has been reported, necessitating validation with knockout controls .

Phospho-S129 Alpha-Synuclein Antibodies in Parkinson’s Research

Phosphorylation at Serine 129 (pS129) is a hallmark of pathological alpha-synuclein aggregates in Parkinson’s disease (PD). Antibodies against pS129-aSyn are used to quantify Lewy body pathology but face specificity challenges.

Table 2: Performance of Common pS129 Antibodies

Antibody CloneSpecificity for pS129Cross-ReactivityPreferred Aggregates Detected
EP1536Y HighLowDense cytoplasmic inclusions
MJF-R13 ModerateNuclear proteins, neurofilamentsPerinuclear aggregates
pSyn#64 ModerateNon-specific HMW bandsSkein-like neuritic aggregates

Critical Observations:

  • EP1536Y shows superior specificity for pathological aggregates in PD brain tissues but may miss truncated aSyn species .

  • Co-occurring C-terminal modifications (e.g., truncation at residue 133/135) reduce detection sensitivity for most pS129 antibodies .

  • False positives arise from cross-reactivity with phosphorylated neurofilaments and nuclear proteins .

Recommendations for Antibody Validation

  1. Controls: Always include SNCA (aSyn) knockout samples to rule out non-specific signals .

  2. Standards: Use site-specifically phosphorylated aSyn proteins for calibration .

  3. Multiplex Staining: Combine with antibodies targeting N- or C-terminal aSyn epitopes to capture truncated aggregates .

Limitations and Future Directions

  • Existing pS129 antibodies underestimate pathology diversity due to insensitivity to adjacent post-translational modifications .

  • Maternal SYN1 autoantibodies may influence neurodevelopmental disorders, but causal links require further study .

Product Specs

Buffer
**Preservative:** 0.03% Proclin 300
**Constituents:** 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
SPDSYN1 antibody; At1g23820 antibody; F5O8.38 antibody; Spermidine synthase 1 antibody; SPDSY 1 antibody; EC 2.5.1.16 antibody; Putrescine aminopropyltransferase 1 antibody
Target Names
SPDSYN1
Uniprot No.

Q&A

SPDSYN1 Antibody Research FAQs

Basic Research Questions

  • How to validate SPDSYN1 antibody specificity in plant nitrogen assimilation studies?

    • Methodological Answer: Perform Western blotting using protein extracts from wild-type and SPDSYN1 knockout mutants. Include controls with recombinant SPDSYN1 protein to confirm target band specificity. For tissue-specific validation, use transgenic lines expressing SPDSYN1 under constitutive (e.g., CaMV 35S) vs. tissue-specific promoters (e.g., root-preferred SUCS or leaf-specific RBCS). Cross-validate with immunohistochemistry in tissues with known nitrogen assimilation activity (e.g., roots, nodules) .

  • What experimental designs optimize SPDSSYN1 antibody use in temporal nitrogen response studies?

    • Methodological Answer: Pair antibody-based protein quantification with transcript-level analysis (RT-qPCR) of SPDSYN1 under nitrogen treatment time courses (0–24 hrs). Use inducible promoters (e.g., glucocorticoid-responsive promoters) to synchronize SPDSYN1 expression. Include internal controls like GLN1.3 or ASN1 (nitrogen storage markers) to contextualize results .

  • How to resolve discrepancies in SPDSYN1 subcellular localization studies?

    • Methodological Answer:

      • Step 1: Validate antibody specificity via immunofluorescence in SPDSYN1-GFP fusion lines.

      • Step 2: Compare localization across fixation protocols (e.g., formaldehyde vs. glutaraldehyde).

      • Step 3: Use subcellular fractionation (e.g., cytosolic vs. organellar extracts) followed by Western blotting. Discrepancies may arise from splice variants or post-translational modifications (e.g., phosphorylation) .

Advanced Research Questions

  • How to analyze SPDSYN1’s role in nitrogen regulatory networks involving CCA1/GLK1/bZIP11?

    • Methodological Answer:

      • Co-IP/MS: Immunoprecipitate SPDSYN1 from nitrogen-treated tissues and identify interacting partners (e.g., CCA1 or bZIP11) via mass spectrometry.

      • Dual-Luciferase Assay: Co-express SPDSYN1 with CCA1-driven reporter constructs to test transcriptional synergy.

      • Mutant Analysis: Compare SPDSYN1 protein levels in cca1, glk1, or bzip11 mutants under high/low nitrogen .

  • What strategies address cross-reactivity in non-model species (e.g., Populus or Glycine max)?

    • Methodological Answer:

      • Epitope Mapping: Compare SPDSYN1 ortholog sequences (e.g., Poptr1#552368 in poplar) to identify conserved regions.

      • Pre-absorption Test: Incubate antibody with heterologous protein lysates (e.g., Arabidopsis vs. soybean) to eliminate non-specific binding.

      • Table: Cross-reactivity validation across species :

        SpeciesOrtholog AccessionAntibody Reactivity (Y/N)
        ArabidopsisAt2g46830Y
        PopulusPoptr1#552368Y (weak)
        Glycine maxGm_SPDSYN1N
  • How to design a CRISPR/Cas9 knockout experiment assessing SPDSYN1’s role in nitrogen storage?

    • Methodological Answer:

      • Step 1: Design sgRNAs targeting conserved domains (e.g., spermidine synthase active site).

      • Step 2: Transform plants using Agrobacterium-mediated methods with a tissue-specific promoter (e.g., root-specific SCARECROW).

      • Step 3: Quantify nitrogen metabolites (e.g., Asn, Gln) in knockout vs. wild-type lines using HPLC. Correlate with SPDSYN1 antibody signal loss .

Data Contradiction Analysis

  • How to interpret conflicting SPDSYN1 expression data in roots vs. leaves under nitrogen stress?

    • Methodological Answer:

      • Hypothesis 1: Tissue-specific promoter leakage (e.g., constitutive vs. inducible systems). Validate using promoter-reporter fusions (e.g., SPDSYN1pro:GUS).

      • Hypothesis 2: Post-transcriptional regulation (e.g., miRNA targeting). Perform RNA-Seq and small RNA sequencing in parallel.

      • Reference: Use GLN1.3 repression dynamics as a negative feedback control .

Technical Optimization

  • Which blocking agents minimize non-specific binding in SPDSYN1 Western blotting?

    • Methodological Answer:

      • Option 1: 5% non-fat milk in TBST (cost-effective but may retain background in lignin-rich tissues).

      • Option 2: 3% BSA + 0.1% Tween-20 (superior for phenolic-rich samples).

      • Critical Step: Pre-block membranes with 0.1% polyvinylpyrrolidone (PVP) for plant-specific secondary metabolite interference .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.